{
    "clinical_study": {
        "@rank": "144563", 
        "acronym": "OAB", 
        "arm_group": {
            "arm_group_label": "Bladder Thermal Distention", 
            "arm_group_type": "Experimental", 
            "description": "Continuous irrigation of the bladder with warm saline (up to 45 Celsius) using a specific 3 ways catheter. The procedure will last 1 hour. Saline will be irrigated by the PelvixTT system."
        }, 
        "brief_summary": {
            "textblock": "In this study, the investigators will evaluate the efficacy of Bladder Thermal Distention\n      (BTD) in patients with overactive bladder syndrome who failed previous treatment of\n      anticholinergic drugs.\n\n      The investigators' hypothesis is that it will improve the storage symptoms."
        }, 
        "brief_title": "Bladder Thermal Distention for Patients With Refractory Overactive Bladder", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Overactive Bladder", 
        "condition_browse": {
            "mesh_term": [
                "Dilatation, Pathologic", 
                "Urinary Bladder, Overactive"
            ]
        }, 
        "detailed_description": {
            "textblock": "Inclusion criteria:\n\n        1. Patients with overactive bladder syndrome\n\n        2. Detrusor Overactivity proven in urodynamic test\n\n      Exclusion criteria:\n\n        1. Mixed urinary incontinence\n\n        2. Active urinary tract infection\n\n        3. Urethral Stricture\n\n      Outcome measures:\n\n        1. Bladder Diaries\n\n        2. Urgency questionnaire"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with overactive bladder syndrome\n\n          -  Detrusor Overactivity proven in urodynamic test\n\n        Exclusion criteria:\n\n          -  Mixed urinary incontinence\n\n          -  Active urinary tract infection\n\n          -  Urethral Stricture"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01842685", 
            "org_study_id": "216/12"
        }, 
        "intervention": {
            "arm_group_label": "Bladder Thermal Distention", 
            "description": "Bladder Thermal Distention is an approved procedure in Europe from 2006. The treatment is hydrodistention of the bladder with a warm saline (up to 45C). The procedure lasts 1 hour. The saline is infused constantly through a 3 ways specific catheter (Unithermia 18F) by the PelvixTT system.", 
            "intervention_name": "Bladder Thermal Distention", 
            "intervention_type": "Procedure", 
            "other_name": "PelvixTT - Hyperthermia Elmedical LTD, Israel"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Overactive Bladder", 
            "Bladder Distention"
        ], 
        "lastchanged_date": "April 25, 2013", 
        "location": {
            "contact": {
                "email": "stavkobi@gmail.com", 
                "last_name": "Kobi Stav, MD", 
                "phone": "972-8-9779400"
            }, 
            "facility": {
                "address": {
                    "city": "Tel Aviv Region", 
                    "country": "Israel", 
                    "state": "Zeriffin", 
                    "zip": "70300"
                }, 
                "name": "Assaf Harofe MC"
            }, 
            "investigator": {
                "last_name": "Kobi Stav, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "1", 
        "official_title": "Bladder Thermal Distention for Patients With Refractory Overactive Bladder", 
        "overall_contact": {
            "email": "stavkobi@gmail.com", 
            "last_name": "Kobi Stav, MD", 
            "phone": "972-8-9778461"
        }, 
        "overall_official": {
            "affiliation": "Assaf Harofe MC", 
            "last_name": "Kobi Stav, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Patients will complete the validated USIQ questionnaire", 
            "measure": "Urgency Questionnaire", 
            "safety_issue": "No", 
            "time_frame": "up to 1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01842685"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Patients will complete bladder diaries before and after the procedure. Frequencies of micturitions per day will be documented", 
            "measure": "Daily frequency of micturitions on Bladder Diary", 
            "safety_issue": "No", 
            "time_frame": "up to 1 year"
        }, 
        "source": "Assaf-Harofeh Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assaf-Harofeh Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}